Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...
As we observe Glaucoma Awareness Month this January, it is essential to recognize the significance of regular eye checkups, ...
The emerging computing power of quantum computers requires new procedures to protect digital information and communication ...
Mossberg’s 590M Mag-Fed design utilizes integral stabilizing ribs on the magazine which engage directly to notches engineered ...
BT’s Openreach snags rural broadband deals worth £289mFCC kickstarts spectrum auction to raise $3bn for rip-and-replace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback